Overall survival from HSCT in 101 patients transplanted beyond CR1. (A) OS as of stage at HSCT [CR2 (dotted curve), untreated relapse (solid curve) and refractory relapse (dashed curve)]. (B) OS as of molecular subgroups [favorable genotype (NPM1mut/FLT3wt, solid curve), versus unfavorable genotypes (NPM1wt/FLT3wt, dotted curve, or FLT3-ITD with or without NPM1mut, dashed curve)]